Study of MK0928 in Healthy Adult Volunteers in a Model of Insomnia (0928-006)(COMPLETED)

Lundbeck

Status and phase: Completed; Phase 3

Conditions: Insomnia

Treatments: Drug: gaboxadol

Study type: Interventional

Funder types: Industry

Identifiers

NCT00102167

0928-006

MK0928-006

2004_092

Details and patient eligibility

About

A study to evaluate the safety and effectiveness of Study of MK0928 in Healthy Adult Volunteers in a Model of Insomnia for insomnia (a sleep disorder).

Enrollment: 663 patients

Sex: All

Ages: 18 to 64 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy adults who are between the ages of 18 and 64

Exclusion criteria

• Adults who are diagnosed with insomnia

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind